UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 153

Sortiert nach

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

Frontiers in oncology, 2021-07, Vol.11, p.707050-707050

2021

Volltextzugriff (PDF)

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

Journal for immunotherapy of cancer, 2021-07, Vol.9 (7), p.e002851

2021

Volltextzugriff (PDF)

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

Frontiers in oncology, 2021-06, Vol.11, p.701345-701345

2021

Volltextzugriff (PDF)

Sleep/Wake Patterns of Individuals With Advanced Cancer Measured by Ambulatory Polysomnography

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2464-2472

2008

Volltextzugriff (PDF)

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Cancer medicine (Malden, MA), 2020-04, Vol.9 (8), p.2752-2760

2020

Volltextzugriff (PDF)

Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma

Molecular aspects of medicine, 2015-11, Vol.45, p.47-54

Harris, Wayne B.

2015

Volltextzugriff (PDF)

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Journal of Immunotherapy and Precision Oncology, 2022-08, Vol.5 (3), p.52-57

2022

Volltextzugriff (PDF)

Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib

Cancer treatment and research communications, 2021, Vol.28, p.100393-100393, Article 100393

2021

Volltextzugriff (PDF)

Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab

Clinical genitourinary cancer, 2018-06, Vol.16 (3), p.e563-e575

2018

Volltextzugriff (PDF)

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The oncologist (Dayton, Ohio), 2020-03, Vol.25 (3), p.e484-e491

2020

Volltextzugriff (PDF)

Immune‐Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The oncologist (Dayton, Ohio), 2021-10, Vol.26 (10), p.e1742-e1750

2021

Volltextzugriff (PDF)

Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors

The oncologist (Dayton, Ohio), 2021-05, Vol.26 (5), p.397-405

2021

Volltextzugriff (PDF)

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

The oncologist (Dayton, Ohio), 2021-12, Vol.26 (12), p.1017-1025

2021

Volltextzugriff (PDF)

External validation of the modified Glasgow prognostic score for renal cancer

Indian journal of urology, 2014-01, Vol.30 (1), p.33-37

2014

Volltextzugriff (PDF)

A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma

Asian Journal of Urology, 2017-10, Vol.4 (4), p.230-238

2017

Volltextzugriff (PDF)

A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors

Clinical cancer research, 2020-06, Vol.26 (11), p.2497-2505

2020

Volltextzugriff (PDF)

Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma

British journal of cancer, 2020-10, Vol.123 (8), p.1228-1234

2020

Volltextzugriff (PDF)

Suppression of Androgen Receptor Expression by Dibenzoylmethane as a Therapeutic Objective in Advanced Prostate Cancer

Anticancer research, 2007-05, Vol.27 (3B), p.1483-1488

2007

Volltextzugriff (PDF)

Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients

Clinical genitourinary cancer, 2022-02, Vol.20 (1), p.53-59

2022

Volltextzugriff (PDF)

Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy

International Journal of Surgical Oncology, 2012-01, Vol.2012, p.524981-6

2012

Volltextzugriff (PDF)

Dibenzoylmethane induces cell cycle deregulation in human prostate cancer cells

Cancer letters, 2002-04, Vol.178 (2), p.161-165

2002

Volltextzugriff (PDF)

Current trends in molecular classification of adult renal tumors

Urology (Ridgewood, N.J.), 2006-05, Vol.67 (5), p.873-880

2006

Volltextzugriff (PDF)

Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients

Tumor biology, 2011-04, Vol.32 (2), p.375-380

2011

Volltextzugriff (PDF)

Dibenzoylmethane, a natural dietary compound, induces HIF-1α and increases expression of VEGF

Biochemical and biophysical research communications, 2003-03, Vol.303 (1), p.279-286

2003

Volltextzugriff (PDF)

Proteomic analysis of proteins altered by dibenzoylmethane in human prostatic cancer LNCaP cells

Proteomics (Weinheim), 2004-09, Vol.4 (9), p.2814-2821

2004

Volltextzugriff (PDF)

1 – 25 von 153

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(130)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(151)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(93)
Life Sciences & Biomedicine
(83)
Humans
(78)
Male
(49)
Female
(40)
Biological And Medical Sciences
(33)
Middle Aged
(24)
Medical Sciences
(23)
Adult
(20)
Oncology
(20)
Aged
(15)
Genetics & Heredity
(14)
Animals
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)
Life Sciences
(13)
Surgery
(12)
Genomes
(11)
Risk Factors
(11)
Medicin Och Hälsovetenskap
(10)
Clinical Medicine
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

Sleep/Wake Patterns of Individuals With Advanced Cancer Measured by Ambulatory Polysomnography

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib

Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab

Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

Immune‐Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

External validation of the modified Glasgow prognostic score for renal cancer

A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma

A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors

Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma

Suppression of Androgen Receptor Expression by Dibenzoylmethane as a Therapeutic Objective in Advanced Prostate Cancer

Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients

Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy

Dibenzoylmethane induces cell cycle deregulation in human prostate cancer cells

Current trends in molecular classification of adult renal tumors

Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients

Dibenzoylmethane, a natural dietary compound, induces HIF-1α and increases expression of VEGF

Proteomic analysis of proteins altered by dibenzoylmethane in human prostatic cancer LNCaP cells

Suchergebnisse filtern